Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
Go back to Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.09 -0.2 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.29 | 52 Week High | $2.18 | |||
| Open | $11.28 | 52 Week Low | $0.30 | |||
| Day High | $11.28 | P/E | N/A | |||
| Day Low | $11.04 | EPS | $-3.32 | |||
| Volume | 121,913 | |||||
